Pre-Open Movers 12/24: (HLF) (NUS) (FB) Higher; (ALXA) (HOV) (AEGR) Lower (more...)

December 24, 2012 9:31 AM EST
Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) 12% LOWER; FDA approved ADASUVE® (loxapine) Inhalation Powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults. ADASUVE combines Alexza's proprietary Staccato® delivery system with the antipsychotic drug, loxapine. The Staccato system is a hand-held inhaler that delivers a drug aerosol to the deep lung that results in rapid systemic delivery and absorption of a drug. See below for Important Safety Information about ADASUVE, including Boxed Warnings.

Hovnanian Enterprises Inc. (NYSE: HOV) 5% LOWER; CEO sells large slug of stock

Aegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) 3% LOWER; FDA approved JUXTAPID (lomitapide) capsules as an adjunct to a low-fat diet and other lipid-lowering treatments, including LDL apheresis where available, to reduce low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), apolipoprotein B (apo B) and non- high-density-lipoprotein cholesterol (non-HDL) in patients with homozygous familial hypercholesterolemia (HoFH).

Herbalife Ltd. (NYSE: HLF) 3% HIGHER; sets analyst meeting on January 10 in response to to short seller attack; says buyback exceeding plan,

Nu Skin Enterprises Inc. (NYSE: NUS) 3% HIGHER; bouncing with HLF

Facebook (NASDAQ: FB) 2% HIGHER; Needham & Company raised estimates and its price target citing strong mobile revenue growth and its scarcity value.

J. C. Penney Company, Inc. (NYSE: JCP) 2% HIGHER; positive comments about promotions at Oppenheimer.

Regions Financial Corp. (NYSE:
RF) 2% LOWER; probed over improper loans - WSJ

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Special Reports

Related Entities

Needham & Company

Add Your Comment